Sentara Enterprises

FDA inspection history in Chesapeake, Virginia, 2015 to 2022

3
Form 483s
1
Warning letter
1
Response

Every document, by year

  • Form 483
  • Warning letter
  • Response

2015: one 483 response and one Form 483; 2016: one warning letter; 2018: one Form 483; 2022: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2015–18Two Form 483s, one 483 response and one warning letter, at Chesapeake, Virginia.
  2. 2015The longest 483 on file: 11 observations over 6 pages at Chesapeake, Virginia.
  3. 2022One Form 483, at Chesapeake, Virginia.

Cited most

Across all Sentara Enterprises observations on file

The complete Sentara Enterprises file.

All 5 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$506$595

15% off buying them one by one

Sites

Documents

5 on file, newest first
DateDocumentPrice
2022-12-16483 Form 483$99
2018-08-06483 Form 483$99
2016-08-08Warning letter Warning letter$99
2015-08-12Response 483 response$199
2015-07-23483 Form 483$99

FEI number 3011627411 · most recent document Dec 16, 2022

About Sentara Enterprises

How many FDA Form 483s has Sentara Enterprises received?

FDA Intel has 3 Form 483s on file for Sentara Enterprises; the most recent is dated Dec 16, 2022.

When was Sentara Enterprises last inspected by FDA?

The most recent FDA inspection document on file for Sentara Enterprises is a Form 483 dated Dec 16, 2022, for the site in Chesapeake, Virginia.

What did FDA cite at Sentara Enterprises?

The regulations cited most in the observations on file for Sentara Enterprises are 21 CFR 211.113 (Control of microbiological contamination), 8 times; FDCA 501(a)(2)(A) (Insanitary conditions), 8 times; 21 CFR 211.42 (Design and construction features), 5 times.

Has Sentara Enterprises received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Sentara Enterprises; the most recent is dated Aug 8, 2016.

Sentara Enterprises FDA Inspection History & 483s · FDA Intel